A series of [Leu5]enkephalin‐related glycoconjugates with an ester‐, ether‐, or amide‐type linkage were synthesized and evaluated for antiviral activity against HIV‐1 in a cell‐culture system using peripheral blood lymphocytes. All tested glycoconjugates exhibited a certain antiviral activity which was significantly higher than the activity of the parent peptide compound itself. These results indicate that synthetic glycoconjugates of opioid peptides are good candidates for the development of anti‐HIV agents.
No takes yet. Share an insight, caveat, or question.
Horvat et al. (1991) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: